Recent Updates
Recently added Catalysts
RIGL Positive Sentiment

Rigel Announces Conference Call and Webcast to Report Second Quarter 2023 Financial Results and Business Update

Tuesday, July 25, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Rigel Pharmaceuticals, Inc. has announced that it will report its second quarter 2023 financial results after market close on August 1, 2023. Following this announcement, the company's senior management will host a live conference call and webcast at 4:30 p.m. Eastern Time. The call aims to discuss the financial results and provide an update on the business operations and pipeline. The webcast will also be available for replay for 90 days following the event.
Price reaction · baseline $12.7 (2023-07-24 close) · hit after-hours · clean, no other RIGL news in the window
day 0 close
-1.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel is preparing to report its second quarter 2023 financial results.
  • The company will provide a business update, which indicates ongoing development.
  • A live conference call will allow investors to engage and receive real-time insights.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+9%
120-day peak, hindsight
Typical move
12.1%
average across 2 past catalysts
Lead asset
Fostamatinib
Phase 2 · Acute Respiratory Distress Syndrome

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., July 25, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2023 financial results after market close on Tuesday, August 1, 2023. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media
Rigel Pharmaceuticals, Inc.
Email: [email protected]

Frequently Asked Questions

When will Rigel Pharmaceuticals report Q2 2023 results?

Rigel Pharmaceuticals will report its Q2 2023 financial results after market close on August 1, 2023.

How can I attend the Rigel conference call?

Participants can dial 877-407-3088 domestically or 201-389-0927 internationally to join.

Is the Rigel conference call available online?

Yes, the conference call will be webcast live and archived for 90 days on their website.

What type of therapies does Rigel develop?

Rigel focuses on novel therapies for hematologic disorders and cancer.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

ShareAdd on Google
Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals Q2 2023 financial results conference call webcast
Last updated: Jul 25, 2023

Biotech snapshot

Cash runway
$95M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FostamatinibPhase 2
Acute Respiratory Distress Syndrome →

Catalyst track record

+9%
best trade around RIGL's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for RIGL.

See every catalyst's timing & PoA →